Interestingly, leukemia, gastric tumor, and brain tumor cells withaltered levels of EZH2 did not respond to EZH2 inhibition by BR-001.Resistance to EZH2 inhibition was formerly linked to increased MLL1expression level and H3K27ac upregulation. Here, EZH2 is linked to brain neoplasm.